Innate Pharma S.A. (0EVI)
LSE • 0EVI • FR0010331421
ORTEX Data Highlights
ORTEX Data Highlights
As of Oct 22, 2026, ORTEX estimated 0.1% of free float sold short, 7.7 days to cover, cost to borrow 96.17%. Sign up for live short interest data.
Market Cap
132m USD | # 3215 in GB
Volume
22k shares | 840.42k USD
Shares Outstanding
93.7m
Free Float Shares
75.17% | 70.43m
